1. Home
  2. EVTL vs IMUX Comparison

EVTL vs IMUX Comparison

Compare EVTL & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vertical Aerospace Ltd.

EVTL

Vertical Aerospace Ltd.

HOLD

Current Price

$0.84

Market Cap

235.6M

Sector

Industrials

ML Signal

HOLD

Logo Immunic Inc.

IMUX

Immunic Inc.

HOLD

Current Price

$16.46

Market Cap

209.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVTL
IMUX
Founded
2016
2016
Country
United Kingdom
United States
Employees
N/A
66
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
235.6M
209.2M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
EVTL
IMUX
Price
$0.84
$16.46
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
6
Target Price
$12.70
$36.00
AVG Volume (30 Days)
7.9M
138.7K
Earning Date
03-24-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.00
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.77
$0.51
52 Week High
$7.35
$16.60

Technical Indicators

Market Signals
Indicator
EVTL
IMUX
Relative Strength Index (RSI) 27.04 64.08
Support Level N/A $0.74
Resistance Level $1.42 N/A
Average True Range (ATR) 0.12 1.05
MACD -0.03 0.16
Stochastic Oscillator 8.18 82.70

Price Performance

Historical Comparison
EVTL
IMUX

About EVTL Vertical Aerospace Ltd.

Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero-emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.

Share on Social Networks: